Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Metabolites
Prif Awduron: Fernandes, Anna Maria A.P., Messias, Marcia C.F., Duarte, Gustavo H.B., de Santis, Gabrielle K.D., Mecatti, Giovana C., Porcari, Andreia M., Murgu, Michael, Simionato, Ana Valéria C., Rocha, Thalita, Martinez, Carlos A.R., Carvalho, Patricia O.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://ncbi.nlm.nih.gov/pubmed/32630389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10060262
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg